Related Experiment Video
Updated: Jun 20, 2025
03:37
Author Spotlight: Enhancing Cerebral Ischemia Research with a Simplified Rat Model
Published on: July 5, 2024
512
Cannabidiol in experimental cerebral ischemia.
Rúbia Maria Weffort de Oliveira1, Nathalia Akemi Kohara1, Humberto Milani1
1Department of Pharmacology and Therapeutics, State University of Maringá, Maringá, Paraná, Brazil.
International Review of Neurobiology
|July 19, 2024
Summary
Cannabidiol (CBD) shows promise for treating cerebral ischemia (CI) by mitigating neuroinflammation and oxidative stress. Further research into CBD
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Cerebral ischemia (CI) involves complex pathophysiological processes like excitotoxicity, oxidative stress, and neuroinflammation.
- Current treatments for CI are limited and can cause adverse effects.
- Novel therapeutic strategies are needed to improve outcomes for cerebral ischemia.
Purpose of the Study:
- To provide a comprehensive overview of Cannabidiol's (CBD) effects on cerebral ischemia (CI).
- To explore the neuroprotective mechanisms of CBD in preclinical models of CI.
Main Methods:
- Review of in vitro studies on CBD and CI.
- Analysis of diverse animal models investigating CBD's efficacy in cerebral ischemia (CI).
- Examination of CBD's interaction with molecular targets relevant to CI pathophysiology.
Main Results:
- Cannabidiol (CBD) demonstrates potential neuroprotective effects in various in vitro and animal models of cerebral ischemia (CI).
- CBD influences multiple pathophysiological pathways implicated in CI, including neuroinflammation and oxidative stress.
- The compound interacts with diverse molecular targets, suggesting a pleiotropic mechanism of action.
Conclusions:
- Cannabidiol (CBD) presents a promising therapeutic candidate for managing cerebral ischemia (CI).
- CBD's multifaceted neuroprotective properties warrant further investigation for clinical application in stroke patients.
- Understanding CBD's mechanisms could lead to innovative treatments for reducing CI-induced brain damage.
